Trial Profile
Daclatasvir plus Asunaprevir treatment in non-hemodialysis and hemodialysis patients infected with genotype 1 hepatitis C virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2018
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 25 Sep 2018 New trial record
- 01 Aug 2018 Results published in the Hepatology Research